Hypoxia regulates the sperm associated antigen 4 (SPAG4) via HIF, which is expressed in renal clear cell carcinoma and promotes migration and invasion in vitro

Molecular Carcinogenesis

Volumn 53, Issue 12, 2014, Pages 970-978

  Knaup, Karl Xaver ^a,b   Monti, Juliana ^a,b   Hackenbeck, Thomas ^a,b   Jobst Schwan, Tilmann ^a   Klanke, Bernd ^a   Schietke, Ruth Elisabeth ^a,b   Wacker, Ingrid ^b   Behrens, Juergen ^b   Amann, Kerstin ^a   Eckardt, Kai Uwe ^a   Warnecke, Christina ^a   Wiesener, Michael Sean ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Cancer; Transcription factor; Translation; Tumor

Indexed keywords

CANCER TESTIS ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; SMALL INTERFERING RNA; SPERM ASSOCIATED ANTIGEN 4; TUMOR MARKER; UNCLASSIFIED DRUG; CARRIER PROTEIN; HYPOXIA INDUCIBLE FACTOR 1; SPAG4 PROTEIN, HUMAN;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CELL MIGRATION; CELL NUCLEUS; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KIDNEY CARCINOMA; REGULATORY MECHANISM; TUMOR INVASION; UPREGULATION; ANOXIA; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; HELA CELL LINE; KIDNEY TUMOR; TUMOR CELL LINE;

ANOXIA; CARCINOMA, RENAL CELL; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; KIDNEY NEOPLASMS; NEOPLASM INVASIVENESS; UP-REGULATION;

EID: 84911450846     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22065     Document Type: Article

References (49)

1. Semenza GL. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE 2007; 2007:cm8.
2. Kaelin WG, Jr. The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma. Clin Cancer Res 2007; 13:680s-684s.
3. Maxwell PH, Wiesener MS, Chang GW, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399:271-275.
4. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16:4604-4613.
5. Ebert BL, Firth JD, Ratcliffe PJ. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J Biol Chem 1995; 270:29083-29089.
6. Wang GL, Semenza GL. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem 1993; 268:21513-21518.
7. Gordan JD, Thompson CB, Simon MC. HIF and c-Myc: Sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 2007; 12:108-113.
8. Knaup KX, Jozefowski K, Schmidt R, et al. Mutual regulation of hypoxia-inducible factor and mammalian target of rapamycin as a function of oxygen availability. Mol Cancer Res 2009; 7:88-98.
9. Hackenbeck T, Knaup KX, Schietke R, et al. HIF-1 or HIF-2 induction is sufficient to achieve cell cycle arrest in NIH3T3 mouse fibroblasts independent from hypoxia. Cell Cycle 2009; 8:1386-1395.
10. Wiesener MS, Munchenhagen PM, Berger I, et al. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Cancer Res 2001; 61:5215-5222.
11. Turner KJ, Moore JW, Jones A, et al. Expression of hypoxia-inducible factors in human renal cancer: Relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res 2002; 62:2957-2961.
12. Mandriota SJ, Turner KJ, Davies DR, et al. HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron. Cancer Cell 2002; 1:459-468.
13. Simpson AJ, Caballero OL, Jungbluth A, et al. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 2005; 5:615-625.
14. Zendman AJ, Ruiter DJ, Van Muijen GN. Cancer/testis-associated genes: Identification, expression profile, and putative function. J Cell Physiol 2003; 194:272-288.
15. Suri A. Cancer testis antigens-Their importance in immunotherapy and in the early detection of cancer. Expert Opin Biol Ther 2006; 6:379-389.
16. Scanlan MJ, Simpson AJ, Old LJ. The cancer/testis genes: Review, standardization, and commentary. Cancer Immun 2004; 4:1.
17. Garg M, Chaurasiya D, Rana R, et al. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer. Clin Cancer Res 2007; 13:1421-1428.
18. Caballero OL, Chen YT. Cancer/testis (CT) antigens: Potential targets for immunotherapy. Cancer Sci 2009; 100:2014-2021.
19. Chen YT, Scanlan MJ, Sahin U, et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 1997; 94:1914-1918.
20. Davis ID, Chen W, Jackson H, et al. Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans. Proc Natl Acad Sci USA 2004; 101:10697-11702.
21. Chen Q, Jackson H, Parente P, et al. Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant. Proc Natl Acad Sci USA 2004; 101:9363-9368.
22. Garg M, Kanojia D, Suri S, et al. Sperm-associated antigen 9: A novel diagnostic marker for thyroid cancer. J Clin Endocrinol Metab 2009; 94:4613-4618.
23. Garg M, Kanojia D, Salhan S, et al. Sperm-associated antigen 9 is a biomarker for early cervical carcinoma. Cancer 2009; 115:2671-2683.
24. Kanojia D, Garg M, Gupta S, et al. Sperm-associated antigen 9, a novel biomarker for early detection of breast cancer. Cancer Epidemiol Biomarkers Prev 2009; 18:630-639.
25. Garg M, Kanojia D, Khosla A, et al. Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma. Cancer Res 2008; 68:8240-8248.
26. Neesse A, Gangeswaran R, Luettges J, et al. Sperm-associated antigen 1 is expressed early in pancreatic tumorigenesis and promotes motility of cancer cells. Oncogene 2007; 26:1533-1545.
27. Tarnasky H, Gill D, Murthy S, et al. A novel testis-specific gene, SPAG4, whose product interacts specifically with outer dense fiber protein ODF27, maps to human chromosome 20q11.2. Cytogenet Cell Genet 1998; 81:65-67.
28. Shao X, Tarnasky HA, Lee JP, et al. Spag4, a novel sperm protein, binds outer dense-fiber protein Odf1 and localizes to microtubules of manchette and axoneme. Dev Biol 1999; 211:109-123.
29. Kennedy C, Sebire K, de Kretser DM, et al. Human sperm associated antigen 4 (SPAG4) is a potential cancer marker. Cell Tissue Res 2004; 315:279-283.
30. Wiesener MS, Münchenhagen MS, Gläser M, et al. Erythropoietin gene expression in renal carcinoma is considerably more frequent than paraneoplastic polycythemia. Int J Cancer 2007; 121(11):2434-2442.
31. Hudson CC, Liu M, Chiang GG, et al. Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol Cell Biol 2002; 22:7004-7014.
32. Wiesener MS, Turley H, Allen WE, et al. Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1alpha. Blood 1998; 92:2260-2268.
33. Parker JM, Guo D, Hodges RS. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: Correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 1986; 25:5425-5432.
34. Janin J. Surface and inside volumes in globular proteins. Nature 1979; 277:491-492.
35. Karplus, PA, Schulz, GE. Bulk hydrophobic scale. Naturwissenschaften 1985; 72, 212-219.
36. Warnecke C, Zaborowska Z, Kurreck J, et al. Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: Erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J 2004; 18:1462-1464.
37. Warnecke C, Weidemann A, Volke M, et al. The specific contribution of hypoxia-inducible factor-2alpha to hypoxic gene expression in vitro is limited and modulated by cell type-specific and exogenous factors. Exp Cell Res 2008; 314:2016-2027.
38. Hackenbeck T, Huber R, Schietke R, et al. The GTPase RAB20 is a HIF target with mitochondrial localization mediating apoptosis in hypoxia. Biochim Biophys Acta 2011; 1813:1-13.
39. Mellor H. Cell motility: Golgi signalling shapes up to ship out. Curr Biol 2004; 14:R434-R435.
40. Wykoff CC, Sotiriou C, Cockman ME, et al. Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene. Br J Cancer 2004; 90:1235-1243.
41. Behrens J, Mareel MM, Van Roy FM, et al. Dissecting tumor cell invasion: Epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 1989; 108:2435-2447.
42. Bertout JA, Patel SA, Simon MC. The impact of O(2) availability on human cancer. Nat Rev Cancer 2008; 8:967-975.
43. Dancey JE, Curiel R, Purvis J. Evaluating temsirolimus activity in multiple tumors: A review of clinical trials. Semin Oncol 2009; 36:S46-S58.
44. Yao JC, Lombard-Bohas C, Baudin E, et al. Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: A phase II trial. J Clin Oncol 2010; 28:69-76.
45. Banerjee S, Flores-Rozas H. Monoclonal antibodies for targeted therapy in colorectal cancer. Cancer Biol Ther 2010; 9 (8):563-571.
46. Langer C, Soria JC. The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancer. Clin Lung Cancer 2010; 11:82-90.
47. De Smet C, De Backer O, Faraoni I, et al. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 1996; 93:7149-7153.
48. Fitzgerald CJ, Oko RJ, van der Hoorn FA. Rat Spag5 associates in somatic cells with endoplasmic reticulum and microtubules but in spermatozoa with outer dense fibers. Mol Reprod Dev 2006; 73:92-100.
49. Yadav S, Puri S, Linstedt AD. A primary role for Golgi positioning in directed secretion, cell polarity, and wound healing. Mol Biol Cell 2009; 20:1728-1736.